{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:57:28Z","timestamp":1792879048251,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11096-018-0724-7","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T01:07:13Z","timestamp":1546564033000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs"],"prefix":"10.1007","volume":"41","author":[{"given":"A.","family":"Chastang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Renet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Corny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Beaussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lillo-Lelouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. T.","family":"Phan Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4352-6996","authenticated-orcid":false,"given":"Y.","family":"B\u00e9zie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"issue":"Suppl 1","key":"724_CR1","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/0976-500X.120957","volume":"4","author":"J Sultana","year":"2013","unstructured":"Sultana J, Cutroneo P, Trifiro G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(Suppl 1):S73\u20137.","journal-title":"J Pharmacol Pharmacother"},{"issue":"7\u20138","key":"724_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1345\/aph.1Q529","volume":"46","author":"KC Sikdar","year":"2012","unstructured":"Sikdar KC, Dowden J, Alaghehbandan R, MacDonald D, Peter P, et al. Adverse drug reactions in elderly hospitalized patients: a 12-year population-based retrospective cohort study. Ann Pharmacother. 2012;46(7\u20138):960\u201371.","journal-title":"Ann Pharmacother"},{"issue":"7\u20138","key":"724_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1345\/aph.1P627","volume":"45","author":"SV Tache","year":"2011","unstructured":"Tache SV, Sonnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother. 2011;45(7\u20138):977\u201389.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"724_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","volume":"38","author":"JC Bouvy","year":"2015","unstructured":"Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437\u201353.","journal-title":"Drug Saf"},{"key":"724_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"79","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;79:1200\u20135.","journal-title":"JAMA"},{"issue":"12","key":"724_CR6","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/pds.1836","volume":"18","author":"G Trifiro","year":"2009","unstructured":"Trifiro G, Pariente A, Coloma PM, Kors JA, Polimeni G, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009;18(12):1176\u201384.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"724_CR7","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1503\/jpn.120256","volume":"38","author":"R Lam","year":"2013","unstructured":"Lam R. Antidepressants and QTc prolongation. J Psychiatry Neurosci. 2013;38(2):E5\u20136.","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"724_CR8","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1503\/jpn.130055","volume":"38","author":"M Hasnain","year":"2013","unstructured":"Hasnain M, Howland RH, Vieweg WV. Escitalopram and QTc prolongation. J Psychiatry Neurosci. 2013;38(4):E11.","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"724_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.rpsm.2013.12.005","volume":"7","author":"E \u00c1lvarez","year":"2014","unstructured":"\u00c1lvarez E, Vieira S, Garcia-Moll X. Citalopram, escitalopram and prolonged QT: warning or alarm? Rev Psiquiatr Salud Ment. 2014;7(3):147\u201350.","journal-title":"Rev Psiquiatr Salud Ment"},{"issue":"10","key":"724_CR10","doi-asserted-by":"publisher","first-page":"e016627","DOI":"10.1136\/bmjopen-2017-016627","volume":"7","author":"A Coughtrie","year":"2017","unstructured":"Coughtrie A, Behr E, Layton D, Marshall V, Camm AJ, et al. Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort. BMJ Open. 2017;7(10):e016627.","journal-title":"BMJ Open"},{"issue":"1","key":"724_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jama.1995.03530010049034","volume":"274","author":"LL Leape","year":"1995","unstructured":"Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995;274(1):35\u201343.","journal-title":"JAMA"},{"issue":"10","key":"724_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","volume":"30","author":"K Johnell","year":"2007","unstructured":"Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007;30(10):911\u20138.","journal-title":"Drug Saf"},{"issue":"4","key":"724_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ajhp\/61.4.380","volume":"61","author":"R Barrons","year":"2004","unstructured":"Barrons R. Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm. 2004;61(4):380\u20135.","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"724_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/msj.20298","volume":"78","author":"J Kannry","year":"2011","unstructured":"Kannry J. Effect of e-prescribing systems on patient safety. Mt Sinai J Med. 2011;78(6):827\u201333.","journal-title":"Mt Sinai J Med"},{"issue":"6","key":"724_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s11606-009-1238-8","volume":"25","author":"R Kaushal","year":"2010","unstructured":"Kaushal R, Kern LM, Barron Y, Quaresimo J, Abramson EL. Electronic prescribing improves medication safety in community-based office practices. J Gen Intern Med. 2010;25(6):530\u20136.","journal-title":"J Gen Intern Med"},{"key":"724_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2046-4053-3-56","volume":"3","author":"TK Nuckols","year":"2014","unstructured":"Nuckols TK, Smith-Spangler C, Morton SC, Asch SM, Patel VM, et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev. 2014;3:56.","journal-title":"Syst Rev"},{"issue":"7","key":"724_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.JAA.0000465221.04234.ca","volume":"28","author":"KG Footracer","year":"2015","unstructured":"Footracer KG. Alert fatigue in electronic health records. JAAPA. 2015;28(7):41\u20132.","journal-title":"JAAPA"},{"issue":"15","key":"724_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jama.280.15.1311","volume":"280","author":"DW Bates","year":"1998","unstructured":"Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;280(15):1311\u20136.","journal-title":"JAMA"},{"issue":"7","key":"724_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/archinte.164.7.785","volume":"164","author":"A Bobb","year":"2004","unstructured":"Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, et al. The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med. 2004;164(7):785\u201392.","journal-title":"Arch Intern Med"},{"key":"724_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2296-11-65","volume":"11","author":"S Anthierens","year":"2010","unstructured":"Anthierens S, Tansens A, Petrovic M, Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract. 2010;11:65.","journal-title":"BMC Fam Pract"},{"issue":"11","key":"724_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"YG Yap","year":"2003","unstructured":"Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89(11):1363\u201372.","journal-title":"Heart"},{"issue":"1","key":"724_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.psym.2014.09.002","volume":"56","author":"RR Tampi","year":"2015","unstructured":"Tampi RR, Balderas M, Carter KV, Tampi DJ, Moca M, et al. Citalopram, QTc prolongation, and torsades de pointes. Psychosomatics. 2015;56(1):36\u201343.","journal-title":"Psychosomatics"},{"issue":"10","key":"724_CR23","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1177\/1060028013501994","volume":"47","author":"KA Funk","year":"2013","unstructured":"Funk KA, Bostwick JR. A comparison of the risk of QT prolongation among SSRIs. Ann Pharmacother. 2013;47(10):1330\u201341.","journal-title":"Ann Pharmacother"},{"key":"724_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40360-016-0053-1","volume":"17","author":"B Wisniowska","year":"2016","unstructured":"Wisniowska B, Tylutki Z, Wyszogrodzka G, Polak S. Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect\u2014comprehensive overview of clinical trials. BMC Pharmacol Toxicol. 2016;17:12.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"7","key":"724_CR25","first-page":"473","volume":"42","author":"M Li","year":"2017","unstructured":"Li M, Ramos LG. Drug-induced QT prolongation and torsades de pointes. P T. 2017;42(7):473\u20137.","journal-title":"P T."},{"issue":"5","key":"724_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385\u201396.","journal-title":"Drug Saf"},{"issue":"6","key":"724_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3810\/pgm.2010.11.2233","volume":"122","author":"R Pushkin","year":"2010","unstructured":"Pushkin R, Frassetto L, Tsourounis C, Segal ES, Kim S. Improving the reporting of adverse drug reactions in the hospital setting. Postgrad Med. 2010;122(6):154\u201364.","journal-title":"Postgrad Med"},{"issue":"1","key":"724_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/0976-9668.107289","volume":"4","author":"SA Khan","year":"2013","unstructured":"Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: an observational study. J Nat Sci Biol Med. 2013;4(1):191\u20136.","journal-title":"J Nat Sci Biol Med"},{"issue":"6","key":"724_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/pds.1155","volume":"15","author":"NM Allen LaPointe","year":"2006","unstructured":"Allen LaPointe NM, Curtis LH, Chan KA, Kramer JM, Lafata JE, et al. Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf. 2006;15(6):361\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"724_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/2045125317721662","volume":"7","author":"AD Meid","year":"2017","unstructured":"Meid AD, Bighelli I, Machler S, Mikus G, Carra G, et al. Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature. Ther Adv Psychopharmacol. 2017;7(12):251\u201364.","journal-title":"Ther Adv Psychopharmacol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-018-0724-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T19:28:11Z","timestamp":1578079691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-018-0724-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1007\/s11096-018-0724-7","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}